Standard BioTools Aktie

Standard BioTools Goodwill

Goodwill for Standard BioTools (LAB) pr. 18. aug. 2026.

Goodwill

0,00USD

Senest opdateret:

Goodwill for Standard BioTools er 2026 0,00 USD. Goodwill for Standard BioTools var 2025 111,30 Mio. USD. Det falder dermed med % lavere sammenlignet med året før.
Access this data via the Eulerpool API

Standard BioTools Aktieanalyse

Hvad laver Standard BioTools? Fluidigm Corp is a biotechnology company specializing in innovative devices and solutions for DNA sequencing. The company was founded in 1999 in San Francisco and is currently headquartered in South San Francisco. It developed the Microfluidic Technology-Sensor, which allows for handling tiny amounts of fluids in a small space. This technology has enabled researchers to analyze complex samples and collect data with high accuracy. The company operates in two main segments: Analytical Instruments and Sample Preparation. In the Analytical Instruments segment, Fluidigm offers various devices suitable for DNA sequencing, including the Juno, C1, and Biomark platforms. It also provides a wide range of consumables to facilitate sample preparation. The Sample Preparation segment offers products and services to prepare and process samples for analysis, including microfluidic technology chips and modules, single-cell sequencing systems, and products for next-generation sequencing. Fluidigm serves customers in various industries, such as genomics research, cancer research, and medical fields, with a strong presence in North America, Europe, and Asia. The company is known for its continuous investment in research and development, as well as its innovative technologies and patents. Overall, Fluidigm's Microfluidic technology platform allows researchers to collect data in a small space with high accuracy. With a diversified portfolio of products and services, the company is well-positioned to continue growing and expanding its market presence in the coming years. Standard BioTools er et af de mest populære virksomheder på Eulerpool.com.

Hyppigt stillede spørgsmål om Standard BioTools aktie

På Eulerpool kan du finde den fuldstændige historiske udvikling af Goodwill Standard BioTools siden 2006 – med årlige værdier, diagrammer og detaljeret analyse.

Goodwill er præmien betalt over fair markedsværdi ved en opkøb. Det repræsenterer immateriel værdi såsom mærkegenkendelse, kundeforhold og intellektuel ejendom.

Goodwills USD er en vigtig faktor for investorer. Ændringer i denne nøgletal kan signalere forbedrede eller forværrede fundamentale forhold, hvilket kan påvirke aktiekursen. På Eulerpool kan du følge Goodwills Standard BioTools historisk.

Access this data via the Eulerpool API

Balance — Standard BioTools

Alle nøgletal — Standard BioTools